User profiles for In-San Kim

In-San Kim

Korea Institute of Science and Technology
Verified email at kist.re.kr
Cited by 24193

Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy

…, Y Choi, GB Kim, S Kim, SA Kim, IS Kim - Advanced …, 2020 - Wiley Online Library
Exosomes are a class of extracellular vesicles of around 100 nm in diameter that are secreted
by most cells and contain various bioactive molecules reflecting their cellular origin and …

TGFBIp/βig-h3 protein: A versatile matrix molecule induced by TGF-β

N Thapa, BH Lee, IS Kim - The international journal of biochemistry & cell …, 2007 - Elsevier
TGFBIp/βig-h3 protein is an extracellular matrix molecule initially cloned from human
adenocarcinoma cells treated with TGF-β. Its precise function remains obscure but a number of …

Bioengineered protein-based nanocage for drug delivery

EJ Lee, NK Lee, IS Kim - Advanced drug delivery reviews, 2016 - Elsevier
Nature, in its wonders, presents and assembles the most intricate and delicate protein
structures and this remarkable phenomenon occurs in all kingdom and phyla of life. Of these …

[HTML][HTML] Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-β-induced gene, βig-h3

JE Kim, SJ Kim, BH Lee, RW Park, KS Kim… - Journal of Biological …, 2000 - ASBMB
βig-h3 is a transforming growth factor-β-inducible cell adhesion molecule that has four
characteristic homologous repeated domains. We made recombinant βig-h3 proteins, which were …

Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel

JH Kim, YS Kim, S Kim, JH Park, K Kim, K Choi… - Journal of controlled …, 2006 - Elsevier
Self-assembled nanoparticles based on hydrophobically modified glycol chitosan (HGC) were
prepared as a carrier for paclitaxel. HGC conjugates were prepared by chemically linking …

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy

…, JH Kim, SM Bae, RW Park, YM Kang, IS Kim… - ACS …, 2011 - ACS Publications
Tumor targetability and site-specific drug release of therapeutic nanoparticles are key
factors for effective cancer therapy. In this study, poly(ethylene glycol) (PEG)-conjugated …

Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring

K Kim, JH Kim, H Park, YS Kim, K Park, H Nam… - Journal of controlled …, 2010 - Elsevier
Theragnostic multifunctional nanoparticles hold great promise in simultaneous diagnosis of
disease, targeted drug delivery with minimal toxicity, and monitoring of treatment. One of the …

Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (β-amino ester) block copolymer micelles for cancer therapy

J Ko, K Park, YS Kim, MS Kim, JK Han, K Kim… - Journal of Controlled …, 2007 - Elsevier
The main objective of this study was to develop and characterize a pH-responsive and
biodegradable polymeric micelle as a tumor-targeting drug delivery system. The pH-responsive …

Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect

…, YW Cho, H Chung, RW Park, IC Kwon, IS Kim… - Journal of Controlled …, 2003 - Elsevier
An in vivo tumor targeting test of glycol-chitosan nanoaggregates was carried out with FITC-conjugated
glycol-chitosan nanoaggregates (FTC-GC) and the doxorubicin conjugated glycol…

Tumoral acidic pH-responsive MPEG-poly (β-amino ester) polymeric micelles for cancer targeting therapy

…, MS Kim, S Park, H Lee, RW Park, IS Kim, K Kim… - Journal of Controlled …, 2010 - Elsevier
Herein, we evaluated the tumoral low pH targeting characteristics of pH-responsive polymer
micelles in cancer targeting therapy. To design the pH-responsive polymeric micelles, …